Agilent Technologies Inc., a prominent provider of bio-analytical and electronic measurement solutions, has reported recent insider activity through several Form 4 disclosures filed on November 17, 2026. These regulatory filings detail changes in beneficial ownership among the company’s senior executives and directors.

According to the disclosures, Mr. Kirkwood Prevost, Mr. Mike Zhang, Mr. Padraig McDonnell, and Ms. Angelica Riemann each surrendered a modest number of shares. These transactions were conducted to satisfy tax liabilities resulting from the vesting of restricted stock units. Additionally, the filings record various purchases and dividend-reinvestment transactions executed under the company’s employee stock purchase and dividend plans, indicating continued participation by insiders.

The filings indicate that there were no significant shifts in share ownership concentration. These updates represent routine insider activity within the laboratory analytical instruments sector and reaffirm the company’s adherence to regulatory reporting requirements.

Agilent Technologies Inc. operates within the health care sector, specifically in the life sciences tools and services industry. The company provides core bio-analytical and electronic measurement solutions to four primary industries: communications, electronics, life sciences, and chemical analysis. Its service portfolio includes electronic and bio-analytical measurement, semiconductor, and board testing services.

As of the market close on November 17, 2026, Agilent Technologies Inc. was trading at 177.33 USD on the New York Stock Exchange. The company maintains a market capitalization of 48,550,000,000 USD and holds a price-to-earnings ratio of 33.82. Over the past 52 weeks, the stock has reached a high of 182.99 USD and a low of 108.35 USD. The company has been publicly traded on the New York Stock Exchange since November 1999.